On July 23, Globe Life Inc. fell 7.64% in regular trading, trading near $170.03/share, with turnover of approximately $170 million. The decline was triggered by the company's second-quarter earnings report, which showed adjusted EPS of $3.61 missing the consensus estimate of $3.67-$3.68 by roughly 1.9%.

While revenue of $1.60 billion rose 8.1% year-over-year and exceeded the $1.59 billion estimate, and management raised full-year EPS guidance to $15.55-$15.95 (up $0.10 at the midpoint), the earnings miss marks the third consecutive quarter of below-consensus profitability. In Q1, EPS of $3.43 missed the $3.47-$3.48 estimate, and in Q4 of the prior year, EPS of $3.39 missed the $3.44 estimate. The persistent shortfall has intensified market concerns over underwriting margin compression and expense-side pressures across the life and health insurance segments.

Globe Life Inc. is an insurance holding company offering life, supplemental health, and annuity products primarily to lower-middle and middle-income households in the United States.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)